Gilead Sciences (GILD) PT Raised at RBC Capital Following Patient Survey
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| Gilead Sciences (NASDAQ: GILD) | Delayed: 174.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $174.48 | 52 Week High | $108.63 | |||
| Open | $174.48 | 52 Week Low | $71.39 | |||
| Day High | $174.48 | P/E | 96.40 | |||
| Day Low | $174.48 | EPS | $1.81 | |||
| Volume | 13,860 | |||||
